A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer
PLOS One · 16.06.2026 · 21 (6) · e0349410
DOI: 10.1371/journal.pone.0349410 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.06.2026. Verfasst von Le-Wei Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Cancer Center and Cancer Institute, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Oncogene Proteins, Fusion. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Municipal Education Commission Scientific Research Innovation Project.
Abstract (Originalsprache)
Breast cancer in young patients, particularly those with the luminal subtype, exhibits more aggressive behavior and poorer clinical outcomes compared with older patients. However, the genomic mechanisms underlying this age-associated aggressiveness remains poorly understood. In this study, we integrated multi-omics data, including gene fusions, mutations, and copy number variations, to investigate age-related molecular heterogeneity in breast cancer. We identified the co-occurrence of the EEF1AKNMT::DNM3 ( ED ) fusion and KDM6B deletion as a novel prognostic biomarker associated with aggressive tumor biology and reduced survival in luminal breast cancer. Moreover, we discovered a widespread pattern of genomic remodeling in early-onset disease, characterized by an increased fusion burden, distinct mutational profiles, and dysregulated transcriptional programs that collectively contribute to high-risk clinical phenotypes. These findings provide mechanistic insights into the enhanced aggressiveness of breast cancer in young patients and identify potential biomarkers for improved risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Cancer Center and Cancer Institute, Fudan University, Shanghai, China.
- Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Ke-Da Yu, Cui-Cui Liu
Förderung
- the National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission Scientific Research Innovation Project
- Wu Jieping Medical Foundation Research Project
- Shanghai Anti-Cancer Association
- Beijing CSCO Clinical Oncology Research Foundation
- Shanghai Aoki Science and Technology Development Foundation
Zitieren
APA
Zheng, L. W., Liu, Y. M., Yu, K. D., & Liu, C. C. (2026). A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer. PLOS One, 21(6), e0349410. https://doi.org/10.1371/journal.pone.0349410
Vancouver
Zheng LW, Liu YM, Yu KD, Liu CC. A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer. PLOS One. 2026;21(6):e0349410. doi:10.1371/journal.pone.0349410
BibTeX
@article{Zheng2026,
author = {Zheng, Le-Wei and Liu, Yi-Ming and Yu, Ke-Da and Liu, Cui-Cui},
title = {A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0349410},
doi = {10.1371/journal.pone.0349410}
}
EUVIMED